[1] Rui J, Niu Y, Wang Q, et al. Containing the transmission of COVID-19: a modelling study in 160 countries. Frontiers in Medicine, 1322.
[2] Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/index.html.
[3] WHO Director-General’s opening remarks at the media briefing on COVID19 -March 2020.
[4] Coronavirus Resource Center, Johns Hopkins University. https://coronavirus.jhu.edu/map.html.
[5] Fauzi M A, Paiman N. COVID-19 pandemic in Southeast Asia: intervention and mitigation efforts. Asian Education and Development Studies, 2020.
[6] Rambaut A, Holmes E C, O’Toole Á, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nature microbiology, 2020, 5(11): 1403-1407.
[7] Dyer O. Covid-19: Indonesia becomes Asia’s new pandemic epicentre as delta variant spreads. BMJ, 2021, 374:n1815.
[8] Chookajorn T, Kochakarn T, Wilasang C, et al. Southeast Asia is an emerging hotspot for COVID-19. Nature Medicine, 2021: 1-2.
[9] IFRC, COVID-19: Southeast Asia battles world’s highest deaths. 18 August 2021. https://reliefweb.int/report/indonesia/covid-19-southeast-asia-battles-world-s-highest-deaths.
[10] ANON. ICMR sero survey. In: Research ICoM, editor. India2021.
[11] Megasari N L A, Utsumi T, Yamani L N, et al. Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia. Plos one, 2021, 16(5): e0251234.
[12] Pandey K R, Bhattarai A, Pant S, et al. Seroprevalence of COVID-19 among health workers in the Kathmandu valley, Nepal (SEVID-KaV): a longitudinal cohort study. 2021.
[13] Ng O T, Marimuthu K, Koh V, et al. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study. The Lancet infectious diseases, 2021, 21(3): 333-343.
[14] Musa S S, Wang X, Zhao S, et al. Heterogeneous Severity of COVID-19 in African Countries: A Modeling Approach. Researchsquare, 2021.
[15] He D, Artzy-Randrup Y, Musa S S, et al. The unexpected dynamics of COVID-19 in Manaus, Brazil: Herd immunity versus interventions. medRxiv, 2021.
[16] WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int/.
[17] Han S M, Lwin K S, Swe K T, et al. Military coup during COVID-19 pandemic and health crisis in Myanmar. BMJ global health, 2021, 6(4): e005801.
[18] Adhikari K. Third wave of COVID-19 in Nepal: challenges and way forward. Journal of Chitwan Medical College, 2021, 11(2): 1-2.
[19] Tanomkiat W. The third COVID-19 wave in Thailand. The ASEAN Journal of Radiology, 2021, 22(1): 03-04.
[20] “SARs-CoV-2 Seroprevalence among the General Population and Healthcare Workers in India, December 2020-January 2021 – Science Direct.” ScienceDirect.Com | Science, Health and Medical Journals, Full Text Articles and Books., http://www.sciencedirect.com/science/article/pii/S120197122100442?via=ihub.
[21] Ni LuhAyuMegasari, et al. “Seriepidemiological study of SARS-CoV-2 Infection in East Java, Indonesia.”, 2021.
[22] Tan IB, Tan C, Hsu LY, et al. Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore. JAMA. 2021;325(6):584–585. doi:10.1001/jama.2020.24071